Matches in DBpedia 2016-04 for { ?s ?p "Fungemia (Fungaemia in the UK and other Commonwealth countries) is the presence of fungi or yeasts in the blood. The most common type, also known as Candidemia, Candedemia, or Invasive Candidiasis, is caused by Candida species, but infections by other fungi, including Saccharomyces, Aspergillus and Cryptococcus, are also called fungemia. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. It has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.Diagnosis is difficult, as routine blood cultures have poor sensitivity."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Fungemia abstract "Fungemia (Fungaemia in the UK and other Commonwealth countries) is the presence of fungi or yeasts in the blood. The most common type, also known as Candidemia, Candedemia, or Invasive Candidiasis, is caused by Candida species, but infections by other fungi, including Saccharomyces, Aspergillus and Cryptococcus, are also called fungemia. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. It has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.Diagnosis is difficult, as routine blood cultures have poor sensitivity.".
- Q3491700 abstract "Fungemia (Fungaemia in the UK and other Commonwealth countries) is the presence of fungi or yeasts in the blood. The most common type, also known as Candidemia, Candedemia, or Invasive Candidiasis, is caused by Candida species, but infections by other fungi, including Saccharomyces, Aspergillus and Cryptococcus, are also called fungemia. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. It has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.Diagnosis is difficult, as routine blood cultures have poor sensitivity.".